BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3439876)

  • 1. Formation of cyanide after i.v. administration of the oxime HI 6 to dogs.
    Eyer P; Kawan A; Ladstetter B
    Arch Toxicol; 1987; 61(1):63-9. PubMed ID: 3439876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
    Spöhrer U; Thiermann H; Klimmek R; Eyer P
    Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pigs poisoned by sarin.
    Worek F; Kirchner T; Szinicz L
    Toxicology; 1995 Jan; 95(1-3):123-33. PubMed ID: 7825179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
    Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
    Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.
    Eyer P; Hagedorn I; Klimmek R; Lippstreu P; Löffler M; Oldiges H; Spöhrer U; Steidl I; Szinicz L; Worek F
    Arch Toxicol; 1992; 66(9):603-21. PubMed ID: 1482283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of intramuscularly administered cyanide antidotes on methemoglobin formation and survival.
    Vick JA; Von Bredow JD
    J Appl Toxicol; 1996; 16(6):509-16. PubMed ID: 8956097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the stability of the oxime HI 6 in aqueous solution.
    Eyer P; Hagedorn I; Ladstetter B
    Arch Toxicol; 1988; 62(2-3):224-6. PubMed ID: 3196158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acetylcholinesterase reactivator HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxyl]methyl]- 2-[(hydroxyimino)methyl]-pyridinium dichloride): a comparative study of HI-6 samples from various sources.
    Clement JG; Lockwood PA; Thompson HG
    Arch Toxicol; 1988; 62(2-3):220-3. PubMed ID: 3196157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice.
    Milic B; Maksimovic M; Nedelijkovic M
    Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes.
    Hill SL; Thomas SH; Flecknell PA; Thomas AA; Morris CM; Henderson D; Dunn M; Blain PG
    Emerg Med J; 2015 Aug; 32(8):626-31. PubMed ID: 25414476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.
    Clement JG; Shiloff JD; Gennings C
    Arch Toxicol; 1987; 61(1):70-5. PubMed ID: 3326546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of methaemoglobin production. (1). Kinetics of methaemoglobinaemia induced by the cyanide antidotes, p-aminopropiophenone, p-hydroxyaminopropiophenone or p-dimethylaminophenol after intravenous administration.
    Marrs TC; Bright JE
    Hum Toxicol; 1986 Sep; 5(5):295-301. PubMed ID: 3770766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats.
    Shiloff JD; Clement JG
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):278-80. PubMed ID: 3299873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the decomposition of the oxime HI 6 in aqueous solution.
    Eyer P; Hell W; Kawan A; Klehr H
    Arch Toxicol; 1986 Dec; 59(4):266-71. PubMed ID: 3827594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.
    Clement JG
    Biochem Pharmacol; 1982 Apr; 31(7):1283-7. PubMed ID: 7092921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicity of the oxime HGG 12 in dogs.
    Klimmek R; Eyer P
    Arch Toxicol; 1985 Sep; 57(4):237-42. PubMed ID: 4091648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal efficacy against carbamate intoxication.
    Harris LW; Talbot BG; Lennox WJ; Anderson DR
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):128-33. PubMed ID: 2494778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.
    Eyer P; Ladstetter B; Schäfer W; Sonnenbichler J
    Arch Toxicol; 1989; 63(1):59-67. PubMed ID: 2742503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of HI-6 in beagle dogs.
    Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.